Tumour-specific STING agonist synthesis via a two-component prodrug system

Journal:

Nature Chemistry

Published:

2025-09-16

DOI:

10.1038/s41557-025-01930-9

Affiliations:

9

Authors:

14

Go to article

Institutions	Authors	Share
University of Cambridge, United Kingdom (UK)	4.833333	0.35
Gulbenkian Institute for Molecular Medicine (GIMM), Portugal	3.833333	0.27
Champalimaud Foundation, Portugal	2.000000	0.14
Alborada Drug Discovery Institute, United Kingdom (UK)	1.500000	0.11
University of La Rioja (UR), Spain	1.000000	0.07
Xi'an Fengcheng Hospital, China	0.500000	0.04
Spanish National Cancer Research Centre (CNIO), Spain	0.333333	0.02

Interested in Immunology?